New Delhi, May 25 (PTI) Several institutes under the Indian Council of Medical Research (ICMR) and innovators on Monday transferred 41 public health technologies to industry partners for further development, manufacturing, and commercialisation.
The technologies included advanced diagnostics, vaccines, medical devices and biomedical solutions addressing critical public health priorities.
Among the technologies transferred were glycoconjugate and recombinant vaccines for typhoid and paratyphoid, as well as diagnostic technologies for diseases such as Japanese encephalitis, tuberculosis, and mpox, a health ministry statement said.
The transfer was made at ‘Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect’ — India’s largest biomedical and technology transfer facilitation event held by ICMR at the Manekshaw Centre.
The event marked the establishment of one of the country’s first structured platforms dedicated to biomedical innovation, showcasing and technology transfer under the ICMR initiative, the statement said.
The venture is aimed at translating indigenous biomedical research into accessible, real-world healthcare solutions through strong industry partnerships, it said.
The event was inaugurated by Union Ayush Minister Prataprao Ganpatrao Jadhav.
“This initiative marks a decisive step in connecting Indian science with industry, ensuring that innovations developed in our laboratories translate into technologies that strengthen public health and advance Viksit Bharat,” Jadhav said, according to the statement.
The minister of state said India is moving from being a consumer of health technologies to becoming a global source of affordable and innovative healthcare solutions, powered by institutions like ICMR and strong industry partnerships.
Dr Gobardhan Das, Member, NITI Aayog, said, India has the scientific capability and innovation ecosystem to emerge as a global leader in health technologies.
“Medical Innovation Patent Mitra will play a crucial role in protecting intellectual property, enabling technology transfer and accelerating the journey of indigenous innovations from laboratories to society,” he said.
ICMR Director General Dr Rajiv Bahl said the initiative reflects ICMR’s commitment to ensuring that cutting-edge research moves beyond laboratories to reach people through strong industry partnerships and impactful technology transfer.
During the event, the ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’ were also released.
In another significant first, well-characterised biomaterials, including inactivated KFD and Chandipura viruses, were transferred to industry partners, the statement said.
The event also showcased more than 100 technologies in diagnostics, therapeutics and medical devices developed by ICMR institutes, researchers and startups, facilitating direct engagement between innovators and industry stakeholders. PTI PLB VN VN
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.